Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermtech Inc (NQ: DMTK )

0.6222 +0.0272 (+4.57%)
Streaming Delayed Price Updated: 10:49 AM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dermtech Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
DermTech Joins PeDRA Corporate Council, Supporting Efforts to Address Pediatric Skin Diseases
From DermTech, Inc.
Via Business Wire
DermTech to Present on Genomic Innovation in Dermatology at AHIP 2022
From DermTech, Inc.
Via Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech: Q4 Earnings Insights
DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
DermTech to Present at the William Blair Growth Stock Conference
From DermTech, Inc.
Via Business Wire
DermTech Sponsors The Sun Bus to Bring Free Skin Cancer Screenings to More Than 50 Locations Across the U.S.
From DermTech, Inc.
Via Business Wire
DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatology’s Annual Meeting
From DermTech, Inc.
Via Business Wire
Looking Into DermTech's Return On Capital Employed
Benzinga Pro data, DermTech (NASDAQ:DMTK) reported Q1 sales of $3.72 million. Earnings fell to a loss of $30.11 million, resulting in a 15.56% decrease from last quarter. 
Via Benzinga
DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program
From DermTech, Inc.
Via Business Wire
DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams
From DermTech
Via Business Wire
DermTech: Q1 Earnings Insights
DermTech (NASDAQ:DMTK) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech missed estimated earnings by... 
Via Benzinga
DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook
From DermTech, Inc.
Via Business Wire
DermTech's Earnings Outlook
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that DermTech will... 
Via Benzinga
DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center
From DermTech, Inc.
Via Business Wire
DermTech Expands Telehealth Application, DermTech Connect, Across 44 States
From DermTech, Inc.
Via Business Wire
DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diego’s Inaugural ‘Innovation Day’ Event
From DermTech, Inc.
Via Business Wire
DermTech Announces Release Date for First-Quarter 2022 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
Earnings Outlook For DermTech
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
DermTech Management to Present at Upcoming Investor Conferences
From DermTech, Inc.
Via Business Wire
DermTech Welcomes Adelle Walker as Vice President of Consumer Products
From DermTech, Inc.
Via Business Wire
DermTech to Announce Fourth Quarter and Full-Year Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Management to Participate in Upcoming Investor Conferences
From DermTech, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Indaptus Therapeutics (NASDAQ:INDP 
Via Benzinga
DermTech Unveils DermTech Stratum, an Expanded Translational Medicine Service Offering for Non-invasive Biomarker Analysis
From DermTech, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
63 Biggest Movers From Friday
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15... 
Via Benzinga
This Is the Main Problem With DermTech's Q3 Results
Nothing major changed for the skin genomics company in Q3. 
Via The Motley Fool
DermTech Presents Precision Approaches to Personalized Dermatology at 2021 Dermatology Drug Development Summit
From DermTech, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.